This triple mechanism distinguishes it from existing approved agents semaglutide, for example, acts on the GLP-1 receptor only, whilst tirzepatide is a dual GIP/GLP-1 receptor agonist and is being investigated to determine whether broader receptor engagement offers additional metabolic benefit
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity
Can Tirzepatide be used for conditions other than weight loss and diabetes
Mean (SD) serum catalase changed by 0.02 (0.03) M for IF group and 0.008 (0.01) M for control group after adjusting for baseline levels
As we age, our bodies produce less glutathione, which hastens to age
Consider HRT For many women, hormone replacement therapy (HRT) can significantly improve sleep by addressing the root cause: declining oestrogen and progesterone